137 related articles for article (PubMed ID: 24117115)
1. Tryptamine induces axonopathy and mitochondriopathy mimicking neurodegenerative diseases via tryptophanyl-tRNA deficiency.
Paley EL; Perry G; Sokolova O
Curr Alzheimer Res; 2013 Nov; 10(9):987-1004. PubMed ID: 24117115
[TBL] [Abstract][Full Text] [Related]
2. Tryptamine-induced tryptophanyl-tRNAtrp deficiency in neurodifferentiation and neurodegeneration interplay: progenitor activation with neurite growth terminated in Alzheimer's disease neuronal vesicularization and fragmentation.
Paley EL
J Alzheimers Dis; 2011; 26(2):263-98. PubMed ID: 21628792
[TBL] [Abstract][Full Text] [Related]
3. Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.
Paley EL; Denisova G; Sokolova O; Posternak N; Wang X; Brownell AL
Neuromolecular Med; 2007; 9(1):55-82. PubMed ID: 17114825
[TBL] [Abstract][Full Text] [Related]
4. Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.
Paley EL; Perry G
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29587458
[TBL] [Abstract][Full Text] [Related]
5. Tryptamine-mediated stabilization of tryptophanyl-tRNA synthetase in human cervical carcinoma cell line.
Paley EL
Cancer Lett; 1999 Mar; 137(1):1-7. PubMed ID: 10376788
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase.
Jorgensen R; Søgaard TM; Rossing AB; Martensen PM; Justesen J
J Biol Chem; 2000 Jun; 275(22):16820-6. PubMed ID: 10828066
[TBL] [Abstract][Full Text] [Related]
7. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
9. Tau and axonopathy in neurodegenerative disorders.
Higuchi M; Lee VM; Trojanowski JQ
Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
[TBL] [Abstract][Full Text] [Related]
10. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies.
Höllerhage M; Matusch A; Champy P; Lombès A; Ruberg M; Oertel WH; Höglinger GU
Exp Neurol; 2009 Nov; 220(1):133-42. PubMed ID: 19682988
[TBL] [Abstract][Full Text] [Related]
11. Diet-Related Metabolic Perturbations of Gut Microbial Shikimate Pathway-Tryptamine-tRNA Aminoacylation-Protein Synthesis in Human Health and Disease.
Paley EL
Int J Tryptophan Res; 2019; 12():1178646919834550. PubMed ID: 30944520
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial fission augments capsaicin-induced axonal degeneration.
Chiang H; Ohno N; Hsieh YL; Mahad DJ; Kikuchi S; Komuro H; Hsieh ST; Trapp BD
Acta Neuropathol; 2015 Jan; 129(1):81-96. PubMed ID: 25322817
[TBL] [Abstract][Full Text] [Related]
13. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus.
Sharma DR; Wani WY; Sunkaria A; Kandimalla RJ; Sharma RK; Verma D; Bal A; Gill KD
Neuroscience; 2016 Jun; 324():163-76. PubMed ID: 26944603
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin.
Rosales-Corral S; Acuna-Castroviejo D; Tan DX; López-Armas G; Cruz-Ramos J; Munoz R; Melnikov VG; Manchester LC; Reiter RJ
Oxid Med Cell Longev; 2012; 2012():843649. PubMed ID: 22666521
[TBL] [Abstract][Full Text] [Related]
15. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
16. Axonal degeneration is mediated by the mitochondrial permeability transition pore.
Barrientos SA; Martinez NW; Yoo S; Jara JS; Zamorano S; Hetz C; Twiss JL; Alvarez J; Court FA
J Neurosci; 2011 Jan; 31(3):966-78. PubMed ID: 21248121
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent axonal degeneration in an Alzheimer mouse model.
Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
[TBL] [Abstract][Full Text] [Related]
18. Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.
Paley EL; Smelyanski L; Malinovskii V; Subbarayan PR; Berdichevsky Y; Posternak N; Gershoni JM; Sokolova O; Denisova G
Mol Immunol; 2007 Jan; 44(4):541-57. PubMed ID: 16616781
[TBL] [Abstract][Full Text] [Related]
19. A concerted tryptophanyl-adenylate-dependent conformational change in Bacillus subtilis tryptophanyl-tRNA synthetase revealed by the fluorescence of Trp92.
Hogue CW; Doublié S; Xue H; Wong JT; Carter CW; Szabo AG
J Mol Biol; 1996 Jul; 260(3):446-66. PubMed ID: 8757806
[TBL] [Abstract][Full Text] [Related]
20. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.
Ferreirinha F; Quattrini A; Pirozzi M; Valsecchi V; Dina G; Broccoli V; Auricchio A; Piemonte F; Tozzi G; Gaeta L; Casari G; Ballabio A; Rugarli EI
J Clin Invest; 2004 Jan; 113(2):231-42. PubMed ID: 14722615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
